Is your MDI composition aligned with your sustainability goals?

Are you aware that Metered Dose Inhalers (MDI) using hydrofluoroalkanes (HFAs) contribute to the world’s carbon footprint, which in turn may affect individuals with pre-existing respiratory disease*? What’s supposed to be a panacea is becoming part of the problem!

Choose what’s best for your patients 

Honeywell’s Solstice Air (HFO-1234ze(E) cGMP) is an alternative technology as a medical propellant, reducing the greenhouse gas emissions of pMDIs by up to 99.9% when compared to current inhaler propellants. Solstice® Air is the only non-flammable, near-zero GWP propellant available and in clinical development today for pMDIs.

*Studies conducted by UNEP and American Lung Association - https://www.unep.org/news-and-stories/story/how-do-greenhouse-gases-actually-warm-planet and https://www.lung.org/getmedia/cfe2481d-1478-4cea-8a77-1ac3eb112e71/what-you-should-know-ways.pdf